CRYOLIFE INC (CRY)
Common Stock
Taking everything into account, CRY scores 2 out of 10 in our fundamental rating. CRY was compared to 192 industry peers in the Health Care Equipment & Supplies industry. CRY has a bad profitability rating. Also its financial health evaluation is rather negative. CRY is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year CRY was profitable.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.16% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.83% | ||
| PM (TTM) | -0.37% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, CRY has more shares outstanding
Compared to 1 year ago, CRY has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.67, we must say that CRY is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 1.00 is on the high side and indicates that CRY has dependencies on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.67 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
CRY has a Current Ratio of 4.21. This indicates that CRY is financially healthy and has no problem in meeting its short term obligations.
CRY has a Quick Ratio of 2.93. This indicates that CRY is financially healthy and has no problem in meeting its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.21 | ||
| Quick Ratio | 2.93 |
3. Growth
3.1 Past
CRY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 130.77%, which is quite impressive.
CRY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.92% yearly.
The Revenue has grown by 40.55% in the past year. This is a very strong growth!
The Revenue has been growing by 11.66% on average over the past years. This is quite good.
EPS 1Y (TTM)130.77%
EPS 3Y-16.84%
EPS 5Y8.92%
EPS growth Q2Q-138.46%
Revenue 1Y (TTM)40.55%
Revenue growth 3Y10.1%
Revenue growth 5Y11.66%
Revenue growth Q2Q10.87%
3.2 Future
CRY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.29% yearly.
The Revenue is expected to grow by 11.66% on average over the next years. This is quite good.
EPS Next Y-91.22%
EPS Next 2Y-45.89%
EPS Next 3Y-4.23%
EPS Next 5Y40.29%
Revenue Next Year18.02%
Revenue Next 2Y14.54%
Revenue Next 3Y12.88%
Revenue Next 5Y11.66%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 59.60, CRY can be considered very expensive at the moment.
CRY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.84.
Based on the Price/Forward Earnings ratio of 265.53, the valuation of CRY can be described as expensive.
The average S&P500 Price/Forward Earnings ratio is at 21.35. CRY is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 59.6 | ||
| Fwd PE | 265.53 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 23.14 |
4.3 Compensation for Growth
A cheap valuation may be justified as CRY's earnings are expected to decrease with -4.23% in the coming years.
PEG (NY)N/A
PEG (5Y)6.68
EPS Next 2Y-45.89%
EPS Next 3Y-4.23%
5. Dividend
5.1 Amount
CRY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CRYOLIFE INC
NYSE:CRY (1/21/2022, 7:51:04 PM)
After market: 17.88 0 (0%)17.88
+0.25 (+1.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap703.22M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 59.6 | ||
| Fwd PE | 265.53 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)6.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.16% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.83% | ||
| PM (TTM) | -0.37% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.21 | ||
| Quick Ratio | 2.93 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)130.77%
EPS 3Y-16.84%
EPS 5Y
EPS growth Q2Q
EPS Next Y-91.22%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)40.55%
Revenue growth 3Y10.1%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y